or Try an Advanced Search...

    Treatment Of Migraine Stocks List

    Symbol Grade Name % Change
    ABBV B AbbVie Inc. -0.67
    AMRX C Amneal Pharmaceuticals, Inc. 1.10
    ASRT C Assertio Therapeutics, Inc. -4.03
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Migraine stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 10.38
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 10.01
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    GRID D First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.31
    FDL A First Trust Morningstar ETF 8.12
    View all Treatment Of Migraine ETFs...
    Compare ETFs
    Compare BOTZ to GRID Compare HDLB to FDL Compare MEDI to GRID

        Treatment Of Migraine Stocks Recent News

        Date Stock Title
        Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
        Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
        Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
        Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
        Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
        Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
        Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
        Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
        Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
        Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
        Jun 28 AMRX Amneal Releases 2023 Environmental, Social and Governance Report
        Jun 28 ABBV AbbVie completes acquisition of Celsius Therapeutics for $250m
        Jun 28 ABBV AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
        Jun 27 ABBV FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
        Jun 27 ABBV Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
        Jun 27 ASRT Assertio: An Extremely Asymmetric Bet Skewed To The Upside
        Jun 27 ABBV AbbVie buys bowel disease drug developer Celsius for $250M
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs
        Treatment Of Migraine

        Treatment of migraine typically involves medications to reduce the intensity of the headache and prevent future attacks. Medications used to treat migraine include triptans, nonsteroidal anti-inflammatory drugs (NSAIDs), antiemetics, and anticonvulsants. Other treatments may include lifestyle modifications, such as avoiding triggers, stress management, and relaxation techniques. In some cases, preventive medications may be prescribed to reduce the frequency and severity of migraine attacks.

        Browse All Tags